EVOKE PHARMA, INC. Accounts Payable and Accrued Liabilities, Current
EVOKE PHARMA, INC. had Accounts Payable and Accrued Liabilities, Current of $3.92 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2025-11-13
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $3.92M.
- 2025-06-30: Accounts Payable and Accrued Liabilities, Current $3.59M.
- 2025-03-31: Accounts Payable and Accrued Liabilities, Current $2.78M.
- 2024-12-31: Accounts Payable and Accrued Liabilities, Current $2.34M.
| Period end | Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2025-09-30 | $3.92M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.59M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.78M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $2.34M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $2.19M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.18M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.95M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $1.71M 10-K · filed 2025-03-13 |
| 2023-09-30 | $1.40M 10-K/A · filed 2024-05-14 |
| 2023-06-30 | $1.42M 10-K/A · filed 2024-05-14 |
| 2023-03-31 | $1.19M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $934.31K 10-K/A · filed 2024-05-14 |
| 2022-09-30 | $1.02M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $824.48K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $944.48K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $874.03K 10-K · filed 2023-03-21 |
| 2021-09-30 | $530.53K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $519.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $691.23K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $1.27M 10-K · filed 2022-03-08 |
| 2020-09-30 | $765.60K 10-Q · filed 2020-11-10 |
| 2020-06-30 | $604.83K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $925.63K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $1.03M 10-K · filed 2021-03-11 |
| 2019-09-30 | $1.15M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $407.52K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $491.83K 10-Q · filed 2019-05-08 |
| 2018-12-31 | $476.20K 10-K · filed 2020-03-12 |
| 2018-09-30 | $625.99K 10-Q · filed 2018-11-13 |
| 2018-06-30 | $441.08K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $545.98K 10-Q · filed 2018-05-14 |
| 2017-12-31 | $1.05M 10-K · filed 2019-03-06 |
| 2017-09-30 | $1.72M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $1.12M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $549.04K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $478.22K 10-K · filed 2018-03-07 |
| 2016-09-30 | $498.13K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.26M 10-Q · filed 2016-08-15 |
| 2016-03-31 | $1.24M 10-Q · filed 2016-05-11 |
| 2015-12-31 | $927.61K 10-K · filed 2017-03-15 |
| 2015-09-30 | $1.34M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $1.37M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $1.35M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $1.01M 10-K · filed 2016-03-10 |
| 2014-09-30 | $1.05M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.30M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $1.12M 10-Q · filed 2014-05-13 |
| 2013-12-31 | $284.92K 10-K · filed 2015-03-04 |
| 2013-09-30 | $1.18M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $96.80K 10-K · filed 2014-03-25 |